van schaik in, bril v, van geloven n, et al. subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (cidp), a multicenter randomised double-blind placebo-controlled trial: the path study. lancet neurol. 2017;17(1):35-46.

Other questions in category

• Which of the following is an indication for endotracheal intubation the need to administer cpap...
• Observing Boards of Pharmacy
• Status epilepticus is seizure activity that lasts longer than five minutes or when seizures occur on...
• Differences between a patient information leaflet and package insert...
• several technologies exist today to help health care professionals determine osteoporosis risk. clic...
• Describe two (2) priority nursing considerations for a client who appears to be having an allergic r...
• Staph bacteria are responsible for____?
• A large earthquake has occurred in a community with one hundred fifty thousand residents, destroying...
• hyper-igm syndrome is a rare genetic disease caused by a loss-of-function mutation in the gene that ...
• A patient has gone into cardiac arrest. Prior to the arrest, a 12-lead ECG showed flat T waves, prom...